Showing results (361-370 of 4,366) with videos related to
Sort By:
Pageof 437
Clinical Immunology (Orlando, Fla.)|December 28, 2016
CD3+CD56+ natural killer T cell activity in children with different forms of juvenile idiopathic arthritis and the influence of etanercept treatment on polyarticular subgroupJuan Zhou, Yuan Ding, Yu Zhang, et al.Clinical Immunology (Orlando, Fla.)|May 13, 2014
Plasmocytoid dendritic cell deficit of early response to toll-like receptor 7 agonist stimulation in multiple sclerosis patientsMarcin P Mycko, Hanna Cwiklinska, Maria Cichalewska, et al.Clinical Immunology (Orlando, Fla.)|May 13, 2014
Membrane lipid interactions in intestinal ischemia/reperfusion-induced InjuryEmily Archer Slone, Sherry D FlemingClinical Immunology (Orlando, Fla.)|May 6, 2014
A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD micePalash Bhattacharya, Jilao Fan, Christine Haddad, et al.Clinical Immunology (Orlando, Fla.)|October 18, 2016
Differential capacity of therapeutic drugs to induce Rods/Rings structures in vitro and in vivo and generation of anti-Rods/Rings autoantibodiesGerson Dierley Keppeke, Monica Simon Prado, Eunice Nunes, et al.Clinical Immunology (Orlando, Fla.)|November 5, 2016
A distinct microbiota composition is associated with protection from food allergy in an oral mouse immunization modelSusanne C Diesner, Cornelia Bergmayr, Barbara Pfitzner, et al.Clinical Immunology (Orlando, Fla.)|January 19, 2017
High-dose BAFF receptor specific mAb-siRNA conjugate generates Fas-expressing B cells in lymph nodes and high-affinity serum autoantibody in a myasthenia mouse modelNaazneen Ibtehaj, Ruksana HudaClinical Immunology (Orlando, Fla.)|February 6, 2017
Anti-BlyS antibody reduces the immune reaction against enzyme and enhances the efficacy of enzyme replacement therapy in Fabry disease model miceYohei Sato, Hiroyuki Ida, Toya OhashiClinical Immunology (Orlando, Fla.)|January 25, 2017
Cadherin-11 as a therapeutic target in chronic, inflammatory rheumatic diseasesPetros P Sfikakis, Nikolaos I Vlachogiannis, Panagiotis F ChristopoulosClinical Immunology (Orlando, Fla.)|July 17, 2003
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumoniaRikke Leth-Larsen, Claudia Nordenbaek, Ida Tornoe, et al.Pageof 437